713-928-2355
Menu
  • Home
  • Practice Areas
    • Personal Injury and Dangerous Devices
      • Philips® CPAP Recall
      • Knee Implant Failure
      • Elbow Implant Failure
      • Shoulder Replacement Lawsuit
      • 3M Earplug Lawsuit
    • Drug Injury
      • Purdue Opioid Claim
      • Invokana © and other SGLT2 Drugs Risk of Fournier Gangrene
      • Invokana® Increased Risk of Leg and Foot Amputations
      • Shingles Vaccine Lawsuit Zostavax®
    • Birth Injury
      • Depakote®
      • Dilantin®
      • Paxil®
      • Zofran®
      • Zoloft®
  • Maritime Injury
  • Buffalo Bayou or SJ River Claim
  • About
    • Victor Longo
  • Testimonials
  • Blog
  • Contact Us
  • Home

Three Children Die From Taking Codeine

The U.S. Food and Drug Administration is currently conducting an investigation into reports of children who developed serious adverse effects or died after taking codeine. The children, between the ages of two and five, were given doses of...
  • More
  • 0
  • 0
  • 0
Posted August 24, 2012 | by victorlongo

FDA Combating Opioid Drug Abuse

The United States Food and Drug Administration (FDA) has announced a new risk reduction program targeting opioid drugs. Opioids are a prescription synthetic drug used to mitigate moderate to severe pain. Many of the opioids are made for use as...
  • More
  • 0
  • 0
  • 0
Posted August 3, 2012 | by victorlongo |in Uncategorized

GNC Moves Away From Ingredient DMAA

General Nutrition Center (GNC) announced it is getting away from dietary supplements containing the controversial ingredient DMAA. Steering away from DMAA products is a significant change for GNC in both marketing and advertising. The company had...
  • More
  • 0
  • 0
  • 0
Posted August 2, 2012 | by victorlongo

Lexapro® Birth Defects

Antidepressant medication is quite common in the United States. More than 11 percent of Americans take some form of antidepressant medication according to the Center for Disease Control (CDC). The CDC funded a study about a possible link between...
  • More
  • 0
  • 0
  • 0
Posted July 12, 2012 | by victorlongo |in Uncategorized

Takeda’s Successor Drug to Actos Fails to Win FDA Approval

Takeda Pharmaceutical Co. is Asia’s largest drug manufacturer and the maker of diabetes drugs. Takeda failed to win clearance to sell its new diabetes drug alogliptin in the United States. FDA regulators are asking for more information on the use...
  • More
  • 0
  • 0
  • 0
Posted July 11, 2012 | by victorlongo |in Uncategorized

Fentanyl Patch Dangers

The fentanyl patch is used to relieve moderate to severe chronic pain. It is sometimes known by the brand name Duragesic®. Duragesic® and other generic fentanyl patches are powerful medication that delivers opioids into the body gradually through...
  • More
  • 0
  • 0
  • 0
Posted June 27, 2012 | by victorlongo |in Uncategorized

Increasing Litigation Against Manufacturers of Transvaginal Mesh

Transvaginal mesh is designed to help with problems of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Transvaginal mesh is a synthetic material and is designed to reinforce the area around the organs in the pelvis area...
  • More
  • 0
  • 0
  • 0
Posted June 13, 2012 | by victorlongo

Pradaxa Ranked as Most Reported Dangerous Drug in 2011

The Institute for Safe Medication Practices publishes the trademarked report QuarterWatch. ISMP analyzed direct reports of the U.S. Food and Drug Administration’s Adverse Event Reporting System (AERS) for 2011. The most frequently...
  • More
  • 0
  • 0
  • 0
Posted June 12, 2012 | by victorlongo |in Uncategorized

85 Percent of Youths Could Expose Themselves to Acetaminophen Overdose

Many teens and young people are dangerously uninformed about over-the-counter medications. A new study enlisted 266 young people in Monroe County, N.Y., between the ages of 16 and 23 in 2008 and 2009. The youths were given the equivalent of a...
  • More
  • 0
  • 0
  • 0
Posted May 31, 2012 | by victorlongo

Fosamax Connected to Rare Thigh Fractures

A new study published on line by the Archives of Internal Medicine said it found a link between bisphosphonate use and atypical thigh fractures. Two of the more commonly used osteoporosis drugs are Fosamax and Actonel. The new study examined the...
  • More
  • 0
  • 0
  • 0
Posted May 24, 2012 | by victorlongo

Cipro, Levaquin, and Other Fluoroquinolones May Cause Retinal Detachment

Levaquin (fluoroquinolone) has been linked to an increased risk of retinal detachment according to the Journal of the American Medical Association. Patients treated by ophthalmologists for retinal detachment were five times more likely to have...
  • More
  • 0
  • 0
  • 0
Posted May 22, 2012 | by victorlongo

$21 Million Awarded in Generic Drug Suit

Generic drug manufacturers cannot use federal law as a bar to personal injury suits that allege flaws in a drug’s design, a federal appeals court has ruled. On May 4th, the 1st U.S. Circuit Court of Appeals upheld a $21 million jury award...
  • More
  • 0
  • 0
  • 0
Posted May 17, 2012 | by victorlongo |in Uncategorized
  • « First
  • « Prev
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • Next »
  • Last »

LikeBox

Phone: 713-928-2355
Fax: 1-713-923-1043
5728 Hood Street
Houston, TX 77023
Disclaimer/Warning This site is a public resource for general information. Nothing in this website should be considered legal advice. Communications by you through this website do not establish an attorney-client relationship. Our professional obligations require that before accepting any new client, we must determine whether any conflicts exist with current or former clients. To inquire about legal representation, please call or email us. An attorney-client relationship will not be created by placing a call or sending an email. Any medical decision is important. You should not stop taking any prescribed medication unless advised to do so by your doctor. Consult your doctor before making any medical decision and do not rely upon this website in making any medical decision. Attorney licensed in Texas. Attorney not certified by the Boards of Legal Specialization in any state. Not all states have board certifications. Attorney Victor Longo is responsible for the content of this advertisement. Representation is not available in all states and Longo Legal, PLLC is not accepting cases in all states. Longo Legal, PLLC may associate with other law firms in other states and jurisdictions as required. Cases will likely be referred to other lawyers for handling. © Copyright 2016 Longo Legal